Ningbo Institute of Life and Health Industry, University of Chinese Academy of Sciences, Ningbo, China.
Hwa Mei Hospital, University of Chinese Academy of Sciences, Ningbo, China.
J Appl Microbiol. 2022 Sep;133(3):1650-1659. doi: 10.1111/jam.15666. Epub 2022 Jun 29.
We aimed at developing a fast and accurate method to detect Vibrio mimicus using real-time recombinase polymerase amplification assay.
Specific primers and probe were designed to target V. mimicus haemolysin (vmh) gene. Target DNA was successfully amplified at 41°C within 20 min. The method exhibited a high level of specificity and the sensitivity was 2.1 × 10 copies/25 μl or 8.4 copies/μl, which is in line with real-time polymerase chain reaction (PCR). The calibration curve plotted by the second-order polynomial regression showed better than the linear curve, as the correlation coefficient was raised to 0.9907, which suggested that the second-order polynomial regressions might be considered to apply to the quantification of real-time recombinase polymerase amplification (RPA). The limit of detection (LOD) was predicted to be 77 copies/25 μl or 3 copies/μl by a probit model. The limit of quantification (LOQ) was calculated to be 28 copies /25 μl or 1 copies/μl by a receiver operating characteristic (ROC) curve, which firstly make LOQ could be available to real-time RPA. For the performance of the real-time RPA in plasma samples, the detection sensitivity of real-time RPA was as good as the real-time PCR. For pretreatment of plasma samples, the boiling method was better than using kits, as it further shortened the time of the real-time RPA in detecting V. mimicus.
The real-time RPA assay developed in our study shows multiple advantages over currently available DNA diagnostic method, including a quicker time-to-result for a single sample, requiring minimal infrastructure and technical support and being tolerant to inhibitors in plasma samples.
The real-time RPA assay developed here is a potentially valuable tool for point-of-care (POC) diagnosis of V. mimicus infection in endemic field, especially in the resources-limited settings, as combined with portable devices.
我们旨在开发一种快速准确的方法,使用实时重组聚合酶扩增检测法来检测 mimic 弧菌。
设计了针对 mimic 弧菌溶血素 (vmh) 基因的特异性引物和探针。在 41°C 下,目标 DNA 在 20 分钟内成功扩增。该方法具有高度特异性,灵敏度为 2.1×10 拷贝/25μl 或 8.4 拷贝/μl,与实时聚合酶链反应 (PCR) 相当。通过二阶多项式回归绘制的校准曲线优于线性曲线,因为相关系数提高到 0.9907,这表明二阶多项式回归可用于实时重组聚合酶扩增 (RPA) 的定量。通过概率单位模型预测检测限 (LOD) 为 77 拷贝/25μl 或 3 拷贝/μl。通过接收者操作特性 (ROC) 曲线计算定量限 (LOQ) 为 28 拷贝/25μl 或 1 拷贝/μl,这是首次使 LOQ 可用于实时 RPA。对于血浆样品中实时 RPA 的性能,实时 RPA 的检测灵敏度与实时 PCR 相当。对于血浆样品的预处理,煮沸法优于试剂盒,因为它进一步缩短了实时 RPA 检测 mimic 弧菌的时间。
本研究中开发的实时 RPA 检测法与现有的 DNA 诊断方法相比具有多种优势,包括单个样本的结果更快、对基础设施和技术支持的要求更低以及对血浆样品中的抑制剂具有耐受性。
这里开发的实时 RPA 检测法是一种有潜力的工具,可用于现场即时检测 mimic 弧菌感染,特别是在资源有限的环境下,与便携式设备结合使用。